BARCLAYS PLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13
+116.7%
105,128
+89.2%
0.00%
Q4 2022$6
-99.4%
55,566
+573.0%
0.00%
Q3 2022$1,000
-88.9%
8,256
-15.5%
0.00%
Q2 2022$9,000
-77.5%
9,774
-69.0%
0.00%
Q1 2022$40,000
-95.6%
31,498
-93.3%
0.00%
Q4 2021$918,000
+321.1%
471,026
+493.3%
0.00%
Q3 2021$218,000
+186.8%
79,396
+228.0%
0.00%
Q2 2021$76,000
+76.7%
24,207
+20.0%
0.00%
Q1 2021$43,00020,1720.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders